Clinical Trials at Rush

Schizophrenia Treatment Study
The Department of Psychiatry is conducting a study to investigate the effectiveness of the drug metformin for preventing metabolic complications, such as weight gain or diabetes, associated with olanzapine in people diagnosed with schizophrenia, schizoaffective disorder, bipolar disorder and/or major depression with psychotic features.

Participants must meet the following criteria:
• Have just started or are about to start taking olanzapine
• Not be diabetic
• Not be pregnant

This is a partial list of inclusion and exclusion criteria. For more information, contact Ferren Farah at (312) 563-3157.

Is A Clinical Trial In Your Future?
Researchers at Rush University Medical Center are committed to finding new ways to prevent and treat disease. Among the dozens of ongoing studies are those on treatments for aging knees, spine problems and other bone and joint health issues. Ask your doctor about whether you would be a good candidate for a clinical trial. To find a list of clinical trials at Rush, visit the Clinical Trials home page.